Fujian Shengdi Pharmaceutical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-12-09
Last Posted Date
2022-09-19
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Target Recruit Count
90
Registration Number
NCT05152277
Locations
🇨🇳

Jinan Central Hospital, Jinan, Shandong, China

A Study of Remimazolam Tosilate for Sedation in the ICU

Phase 2
Completed
Conditions
Interventions
First Posted Date
2021-12-09
Last Posted Date
2023-05-23
Lead Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Target Recruit Count
60
Registration Number
NCT05152303
Locations
🇨🇳

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

© Copyright 2024. All Rights Reserved by MedPath